104 related articles for article (PubMed ID: 11169138)
21. Cloning of the amino terminal nucleotides of the antigen I/II of Streptococcus sobrinus and the immune responses to the corresponding synthetic peptides.
Staffileno LK; Hendricks M; LaPolla R; Bohart C; Van Hook P; Rosen JI; Warner J; Hoey K; Wegemer D; Naso RB
Arch Oral Biol; 1990; 35 Suppl():47S-52S. PubMed ID: 2088235
[TBL] [Abstract][Full Text] [Related]
22. Flagellin-rPAc vaccine inhibits biofilm formation but not proliferation of S. mutans.
Sun Y; Yang Y; Zhou D; Cao Y; Yu J; Zhao B; Zhong M; Li Y; Yang J; Yan H
Hum Vaccin Immunother; 2016 Nov; 12(11):2847-2854. PubMed ID: 27392114
[TBL] [Abstract][Full Text] [Related]
23. Characterization of epitopes recognized by anti-Streptococcus mutans P1 monoclonal antibodies.
McArthur WP; Rhodin NR; Seifert TB; Oli MW; Robinette RA; Demuth DR; Brady LJ
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):342-53. PubMed ID: 17535300
[TBL] [Abstract][Full Text] [Related]
24. Sublingual immunization with the phosphate-binding-protein (PstS) reduces oral colonization by Streptococcus mutans.
Ferreira EL; Batista MT; Cavalcante RC; Pegos VR; Passos HM; Silva DA; Balan A; Ferreira LC; Ferreira RC
Mol Oral Microbiol; 2016 Oct; 31(5):410-22. PubMed ID: 26462737
[TBL] [Abstract][Full Text] [Related]
25. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
Saito M; Otake S; Ohmura M; Hirasawa M; Takada K; Mega J; Takahashi I; Kiyono H; McGhee JR; Takeda Y; Yamamoto M
J Infect Dis; 2001 Mar; 183(5):823-6. PubMed ID: 11181162
[TBL] [Abstract][Full Text] [Related]
26. [The experimental study of immunization with purified surface protein antigen I/II from streptococcus mutans in BALB/c mice].
Fan M; Du M; Bian Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 May; 33(3):149-51. PubMed ID: 11774416
[TBL] [Abstract][Full Text] [Related]
27. [Protective efficacy of a new fusion anti-caries DNA vaccine encoding antigens of both Streptococcus mutans and Streptococcus sobrinus].
Sun JH; Niu YM; Fan MW; Xu QA; Yang XC
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2286-91. PubMed ID: 20095345
[TBL] [Abstract][Full Text] [Related]
28. Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine.
Sun Y; Shi W; Yang JY; Zhou DH; Chen YQ; Zhang Y; Yang Y; He BX; Zhong MH; Li YM; Cao Y; Xiao Y; Li W; Yu J; Li YH; Fan MW; Yan HM
J Dent Res; 2012 Oct; 91(10):941-7. PubMed ID: 22895510
[TBL] [Abstract][Full Text] [Related]
29. Effects of antibodies against a fusion protein consisting of parts of cell surface protein antigen and glucosyltransferase of Streptococcus sobrinus on cell adhesion of mutans streptococci.
Kawato T; Yamashita Y; Katono T; Kimura A; Maeno M
Oral Microbiol Immunol; 2008 Feb; 23(1):14-20. PubMed ID: 18173793
[TBL] [Abstract][Full Text] [Related]
30. Antigenic cross-reactivity and functional inhibition by antibodies to Clostridium difficile toxin A, Streptococcus mutans glucan-binding protein, and a synthetic peptide.
Wren BW; Russell RR; Tabaqchali S
Infect Immun; 1991 Sep; 59(9):3151-5. PubMed ID: 1715320
[TBL] [Abstract][Full Text] [Related]
31. Regulation and specificity of the immune response to an oral Streptococcus mutans antigen by T-cell helper and suppressor factors and B-cell antibodies.
Lamb JR; Zanders ED; Kontiainen S; Lehner T
Arch Oral Biol; 1981; 26(9):745-51. PubMed ID: 6175296
[No Abstract] [Full Text] [Related]
32. Human IgG and Streptococcus mutans SR protein contain cross-reactive epitopes.
Wachsmann D; Ackermans F; Vincenzotto C; Scholler M; Bazin H; Ogier J; Klein JP
J Immunol; 1989 Dec; 143(12):4257-62. PubMed ID: 2480390
[TBL] [Abstract][Full Text] [Related]
33. Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2.
Jones GL; Spencer L; Lord R; Saul AJ
Vaccine; 1996 Jan; 14(1):77-84. PubMed ID: 8821653
[TBL] [Abstract][Full Text] [Related]
34. Distribution of cross-reactive antigens A and B in Streptococcus mutans and other oral streptococci.
Russell RR
J Gen Microbiol; 1980 Jun; 118(2):383-8. PubMed ID: 7441199
[TBL] [Abstract][Full Text] [Related]
35. Epitope mapping of Streptococcus mutans SR protein and human IgG cross-reactive determinants, by using recombinant proteins and synthetic peptides.
Gangloff S; M'Zoughi R; Lett E; Scholler M; Baer J; Pini A; Ogier J; Klein JP
J Immunol; 1992 May; 148(10):3249-55. PubMed ID: 1374451
[TBL] [Abstract][Full Text] [Related]
36. Alterations in immunodominance of Streptococcus mutans AgI/II: lessons learned from immunomodulatory antibodies.
Robinette RA; Heim KP; Oli MW; Crowley PJ; McArthur WP; Brady LJ
Vaccine; 2014 Jan; 32(3):375-82. PubMed ID: 24252705
[TBL] [Abstract][Full Text] [Related]
37. Identification of T- and B-cell epitopes in synthetic peptides derived from a Streptococcus mutans protein and characterization of their antigenicity and immunogenicity.
Lehner T; Walker P; Smerdon R; Childerstone A; Bergmeier LA; Haron J
Arch Oral Biol; 1990; 35 Suppl():39S-45S. PubMed ID: 1708230
[TBL] [Abstract][Full Text] [Related]
38. Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross-reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy.
Cachia PJ; Kao DJ; Hodges RS
J Mol Recognit; 2004; 17(6):540-57. PubMed ID: 15386623
[TBL] [Abstract][Full Text] [Related]
39. Streptococcus mutans and the problem of heart cross-reactivity.
Russell MW; Wu HY
Crit Rev Oral Biol Med; 1990; 1(3):191-205. PubMed ID: 2129625
[TBL] [Abstract][Full Text] [Related]
40. Comparative immunogenicity and protective effect against dental caries of a low (3800) and a high (185,000) molecular weight protein in rhesus monkeys (Macaca mulatta).
Lehner T; Caldwell J; Giasuddin AS
Arch Oral Biol; 1985; 30(3):207-12. PubMed ID: 2581533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
